The present invention relates to immunotherapeutic peptides and their use in immunotherapy, in particular the immunotherapy of cancer. The present invention discloses tumor-associated T-helper cell peptide epitopes, alone or in combination with other tumor-associated peptides that serve as active pharmaceutical ingredients of vaccine compositions which stimulate anti-tumor immune responses. In particular, the composition of the peptides of the present invention can be used in vaccine compositions for eliciting anti-tumor immune responses against gastric cancers (GC).本發明涉及免疫治療肽及其在免疫療法，特別是癌症免疫療法中的用途。本發明披露了單獨形式的或與其他腫瘤相關肽(刺激抗腫瘤免疫反應疫苗組合物的活性藥物成分)組合形式的腫瘤相關T輔助細胞肽表位。特別是本發明的肽組合物可用於引發胃癌(GC)抗腫瘤免疫反應的疫苗化合物。
